Short answer
VIEMED HEALTHCARE, INC. (VMD) filed its Q2 2026 10-Q quarterly report on Aug 3, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $78M (up 23.9% year over year) with net income of $3M.
Q2 2026 key financials · XBRL
- Revenue
- $78M
- +23.9% YoY · +3.6% QoQ
- Net income
- $3M
- −12.4% YoY · +7.0% QoQ
- Operating margin
- 5.7%
- Gross margin
- 57.7%
- EPS (diluted)
- $0.07
- −12.5% YoY · +16.7% QoQ
Source: XBRL data from the VIEMED HEALTHCARE, INC. (VMD) Q2 2026 10-Q on SEC EDGAR. USD.
VIEMED HEALTHCARE, INC. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material risk-factor changes from the December 31, 2025 Form 10-K
- Credit-facility distribution restrictions limiting subsidiary dividend payments under the 2022 Senior Credit Facilities
- Share-repurchase liquidity use: 535,260 shares purchased for $9.65 average price during the quarter
- Remaining repurchase authorization of 1,249,329 shares through March 2027
- No newly triggered regulatory, legal, or compliance risk disclosed this quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other VIEMED HEALTHCARE, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.